akhatri

MHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) Drug alert number: EL(25)A/02 Date issued: 13 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) [...]

The post MHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.

As ‘FS’ endorsed prescription items become more common, Community Pharmacy England has released updated guidance on how pharmacies should handle these prescriptions. Community pharmacies are seeing an increase in electronic prescriptions with items endorsed ‘FS’ for free supply of sexual health treatment. This increase has been partially driven by the adoption of EPS by sexual [...]

The post Guidance on handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Nyzamac® SR 60mg capsules is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP076 Nyzamac® SR 60mg capsules expires at 23.59pm on Friday 8 November 2024. After this date, any prescriptions for Nyzamac® SR 60mg [...]

The post Expiry of SSP076 Nyzamac® SR 60mg capsules appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) Drug alert number: EL (24)A/53 Date issued: 07 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen [...]

The post MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 4 November 2024) has been published and includes articles on: MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety Letters and medicine recalls sent to healthcare professionals in October 2024 To see the [...]

The post MHRA Drug Safety Update: November 2024 appeared first on Community Pharmacy England.